NO20076542L - Fremgangsmate for fremstilling av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol - Google Patents

Fremgangsmate for fremstilling av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol

Info

Publication number
NO20076542L
NO20076542L NO20076542A NO20076542A NO20076542L NO 20076542 L NO20076542 L NO 20076542L NO 20076542 A NO20076542 A NO 20076542A NO 20076542 A NO20076542 A NO 20076542A NO 20076542 L NO20076542 L NO 20076542L
Authority
NO
Norway
Prior art keywords
alpha
beta
naphthalenyl
dimethylamino
bromo
Prior art date
Application number
NO20076542A
Other languages
English (en)
Other versions
NO341633B1 (no
Inventor
Frank Ralf Porstmann
Stefan Horns
Thomas Bader
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20076542L publication Critical patent/NO20076542L/no
Publication of NO341633B1 publication Critical patent/NO341633B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Foreliggende oppfinnelse vedrører en fremgangsmåte for å isolere (?S, ?R)-6-brom-?- [2-(dimetylamino)etyl]-2-metoksy-?-1-naftalenyl-?-fenyl-3-kinolinetanol fra en blanding av stereoisomere former av 6-brom-?-[2-(dimetylamino)etyl]-2-metoksy-?-1-naftalenyl-?-fenyl-3-kinolinetanol ved optisk oppløsning med kiralt 4-hydroksdiynafto[2,1-d:1',2'-f][1,3,2]dioksafosfepin 4-oksid eller et derivat derav, spesielt (11bR)-4-hydroksdiynafto[2,1-d:1',2'-f][1,3,2]dioksafosfepin 4-oksid, som løsemiddel.
NO20076542A 2005-05-25 2007-12-19 Fremgangsmåte for fremstilling av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol NO341633B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05104482 2005-05-25
PCT/EP2006/062502 WO2006125769A1 (en) 2005-05-25 2006-05-22 Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol

Publications (2)

Publication Number Publication Date
NO20076542L true NO20076542L (no) 2007-12-19
NO341633B1 NO341633B1 (no) 2017-12-11

Family

ID=36013279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076542A NO341633B1 (no) 2005-05-25 2007-12-19 Fremgangsmåte for fremstilling av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol

Country Status (27)

Country Link
US (2) US8039628B2 (no)
EP (1) EP1888604B1 (no)
JP (1) JP5410749B2 (no)
KR (2) KR101534021B1 (no)
CN (1) CN101180302B (no)
AT (1) ATE549343T1 (no)
AU (1) AU2006251208B2 (no)
BR (1) BRPI0611166B1 (no)
CA (1) CA2606675C (no)
CY (1) CY1113383T1 (no)
DK (1) DK1888604T3 (no)
EA (1) EA011770B1 (no)
ES (1) ES2383908T3 (no)
HR (1) HRP20120429T1 (no)
IL (1) IL186913A (no)
ME (1) ME01445B (no)
MX (1) MX2007014874A (no)
NO (1) NO341633B1 (no)
NZ (1) NZ563819A (no)
PL (1) PL1888604T3 (no)
PT (1) PT1888604E (no)
RS (1) RS52316B (no)
SG (1) SG162724A1 (no)
SI (1) SI1888604T1 (no)
UA (1) UA92484C2 (no)
WO (1) WO2006125769A1 (no)
ZA (1) ZA200710150B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2668715B2 (ja) 1988-10-21 1997-10-27 住友重機械工業株式会社 コイル集束装置における切断制御法
EP1835115B1 (de) 2006-03-17 2013-05-29 Peter Villiger Schutzverfahren und Schutzsystem für Wertsachen
RU2486175C2 (ru) * 2011-09-12 2013-06-27 Закрытое Акционерное Общество "Фарм-Синтез" Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases
CN105017147B (zh) * 2014-04-30 2019-02-01 中国医学科学院药物研究所 一种回收和利用Bedaquiline立体化学异构体的方法
CN105085395B (zh) * 2014-05-07 2017-09-26 国药集团国瑞药业有限公司 贝达喹啉的制备方法
CN105085396B (zh) * 2014-05-07 2017-08-08 国药集团国瑞药业有限公司 用于制备贝达喹啉的中间体及其制备方法和应用
CN105198808B (zh) * 2014-05-27 2017-08-25 北京万生药业有限责任公司 一种高效生产贝达喹啉的方法
CN105175329B (zh) * 2014-06-10 2017-09-19 重庆圣华曦药业股份有限公司 一种贝达喹啉消旋体的合成路线及方法
CZ2014708A3 (cs) 2014-10-16 2016-04-27 Zentiva, K.S. Soli Bedaquilinu
CZ201535A3 (cs) 2015-01-21 2016-08-03 Zentiva, K.S. Nové možnosti chirální resoluce bedaquilinu
CZ201533A3 (cs) 2015-01-21 2016-08-03 Zentiva, K.S. Způsob izolace směsi enantiomerů
CZ201534A3 (cs) 2015-01-21 2016-08-03 Zentiva, K.S. Nové možnosti chirální resoluce bedaquilinu
LT3250182T (lt) * 2015-01-27 2023-07-10 Janssen Pharmaceutica Nv Dispersinės kompozicijos
CZ2015391A3 (cs) 2015-06-09 2016-12-21 Zentiva, K.S. Sůl bedaquilinu s kyselinou citronovou
CN107848978B (zh) * 2015-07-24 2021-04-02 浙江海正药业股份有限公司 一种分离贝达喹啉非对映异构体a的方法
ES2934785T3 (es) 2016-03-07 2023-02-27 Global Alliance For Tb Drug Development Inc Compuestos antibacterianos y usos de los mismos
CN107602464B (zh) * 2016-07-12 2020-02-18 宜昌人福药业有限责任公司 利用光学拆分制备双芳基喹啉类抗生素的方法
CN106866525B (zh) * 2017-03-24 2019-04-19 福建省微生物研究所 用于合成(1r,2s)-贝达喹啉的手性诱导剂
JOP20200004B1 (ar) 2017-07-14 2023-09-17 Janssen Pharmaceutica Nv تركيبات طويلة المفعول
CN109422679B (zh) * 2017-08-30 2021-06-25 武汉武药科技有限公司 一种贝达喹啉的纯化及稳定晶型的制备方法
CN107857727B (zh) * 2017-10-26 2019-10-18 江苏天和制药有限公司 一种（1r，2s）和（1s，2r）-贝达喹啉的制备方法
CN110759885B (zh) * 2018-07-27 2021-10-22 中国医学科学院药物研究所 制备光活依格鲁特的方法
WO2020161743A1 (en) 2019-02-08 2020-08-13 Mylan Laboratories Limited Process for the preparation of bedaquiline fumarate
KR102303635B1 (ko) * 2020-07-01 2021-09-17 동아에스티 주식회사 (1r,2s)-1-(6-브로모-2-메톡시퀴놀린-3-일)-4-디메틸아미노-2-(1-나프틸)-1-페닐-부탄-2-올 및 이의 약제학적으로 허용 가능한 염의 제조방법
KR20230038521A (ko) 2020-07-09 2023-03-20 얀센 파마슈티카 엔.브이. 장기 작용 제형
JP2023532982A (ja) 2020-07-09 2023-08-01 ヤンセン ファーマシューティカ エヌ．ベー． 長時間作用型配合物
US20240277614A1 (en) 2020-07-09 2024-08-22 Janssen Pharmaceutica Nv Long-acting formulations
WO2024068699A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
WO2024068693A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
JP7728461B1 (ja) 2023-08-01 2025-08-22 上海交通大学 低温で連続フローによりベダキリンを調製する方法及びこの方法により調製された製品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2111138A1 (en) * 1993-01-15 1994-07-16 Thierry Godel Octahydrophenanthrene derivatives
US5319084A (en) * 1993-08-16 1994-06-07 Research Triangle Institute Hexahydroindenopyridine compounds having antispermatogenic activity
DK1527050T3 (da) * 2002-07-25 2010-07-19 Janssen Pharmaceutica Nv Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
WO2004060889A1 (en) * 2003-01-07 2004-07-22 Glaxo Group Limited 5-thiazole substituted 2-pyrrolidine-carboxylic acids

Also Published As

Publication number Publication date
US8350040B2 (en) 2013-01-08
CA2606675A1 (en) 2006-11-30
BRPI0611166A2 (pt) 2010-08-17
WO2006125769A1 (en) 2006-11-30
AU2006251208B2 (en) 2012-11-29
RS52316B (sr) 2012-12-31
KR20080010453A (ko) 2008-01-30
ME01445B (me) 2013-12-20
US20080200683A1 (en) 2008-08-21
SI1888604T1 (sl) 2012-08-31
AU2006251208A1 (en) 2006-11-30
HRP20120429T1 (hr) 2012-06-30
CA2606675C (en) 2013-02-19
HK1118061A1 (en) 2009-01-30
EP1888604A1 (en) 2008-02-20
MX2007014874A (es) 2008-02-15
IL186913A0 (en) 2008-02-09
SG162724A1 (en) 2010-07-29
CY1113383T1 (el) 2016-06-22
NZ563819A (en) 2011-01-28
EP1888604B1 (en) 2012-03-14
BRPI0611166B1 (pt) 2022-01-25
US20110319623A1 (en) 2011-12-29
UA92484C2 (en) 2010-11-10
ZA200710150B (en) 2012-06-27
EA011770B1 (ru) 2009-06-30
KR20150008196A (ko) 2015-01-21
KR101534021B1 (ko) 2015-07-06
DK1888604T3 (da) 2012-06-18
IL186913A (en) 2013-12-31
NO341633B1 (no) 2017-12-11
CN101180302A (zh) 2008-05-14
EA200702611A1 (ru) 2008-04-28
PL1888604T3 (pl) 2012-08-31
US8039628B2 (en) 2011-10-18
PT1888604E (pt) 2012-05-28
ATE549343T1 (de) 2012-03-15
JP5410749B2 (ja) 2014-02-05
ES2383908T3 (es) 2012-06-27
KR101712835B1 (ko) 2017-03-07
JP2008545675A (ja) 2008-12-18
CN101180302B (zh) 2013-06-19

Similar Documents

Publication Publication Date Title
NO20076542L (no) Fremgangsmate for fremstilling av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
MY152283A (en) Polo-like kinase inhibitirs
MY150542A (en) Cmet inhibitors
TW200728307A (en) Novel spirochromanone derivatives
BRPI0712631B8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
GB0719180D0 (en) New process
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
AU2008255733A8 (en) Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
TW200833682A (en) Pharmaceutical compounds
MA29464B1 (fr) Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues
BRPI0809981A2 (pt) Compostos, processo de fabricação destes, composição farmacêutica que os contém, método de tratamento e/ou prevenção de doenças que são associadas a modulação de receptores de sst subtipo 5 e uso dos compostos.
MX2010004669A (es) Proceso para la preparacion de derivados de isoindol asi como tambien un proceso para la preparacion de sus intermediarios.
EP2077846A4 (en) BENZOXAZEPINE COMPOUNDS, PREPARATION THEREOF AND USE THEREOF
CU20100099A7 (es) 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antinflamatorios
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
MY142474A (en) 1h-quinazoline-2,4-diones
WO2007104485A3 (de) Substituierte imidazo[2,1-b]thiazol-verbindungen und ihre verwendung zur herstellung von arzneimitteln
BRPI0518613A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo de preparar uma composiÇço, e, uso de um composto
BRPI0517390B8 (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepam
BRPI0606639A2 (pt) novo processo para a preparação de indóis substituìdos
TW200612959A (en) Method for preparing hydroxamic acids
TW200740729A (en) Methods for preparing glutamic acid derivatives